iPSC-Derived Noradrenergic Neurons
<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">iPSC-Derived Noradrenergic Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Stem Cell > iPSC > Noradrenergic</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>DBH, TH, PHOX2A</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>In Vitro</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Parkinson's Disease, Depression</td>
</tr>
</table>
iPSC-Derived Noradrenergic Neurons
Overview
flowchart TD
IPSC["IPSC"] -->|"activates"| MOTOR_NEURONS["MOTOR NEURONS"]
IPSC["IPSC"] -->|"activates"| STEM_CELLS["STEM CELLS"]
IPSC["IPSC"] -->|"activates"| NEURON["NEURON"]
IPSC["IPSC"] -->|"activates"| TAU["TAU"]
IPSC["IPSC"] -->|"activates"| ORGANOIDS["ORGANOIDS"]
IPSC["IPSC"] -->|"inhibits"| NEURON["NEURON"]
IPSC["IPSC"] -->|"interacts with"| NEURON["NEURON"]
Ipsc["Ipsc"] -->|"involved in"| Aging["Aging"]
Ipsc["Ipsc"] -->|"associated with"| Midbrain_Dopaminergic_Neurons["Midbrain Dopaminergic Neurons"]
IPSC["IPSC"] -->|"activates"| TDP_43["TDP-43"]
IPSC["IPSC"] -->|"activates"| MICROGLIA["MICROGLIA"]
IPSC["IPSC"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
Ipsc["Ipsc"] -->|"associated with"| Astrocytes["Astrocytes"]
IPSC["IPSC"] -->|"causes"| NEURON["NEURON"]
style IPSC fill:#4fc3f7,stroke:#333,color:#000
...iPSC-Derived Noradrenergic Neurons
<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">iPSC-Derived Noradrenergic Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Stem Cell > iPSC > Noradrenergic</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>DBH, TH, PHOX2A</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>In Vitro</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Parkinson's Disease, Depression</td>
</tr>
</table>
iPSC-Derived Noradrenergic Neurons
Overview
Mermaid diagram (expand to render)
iPSC-derived noradrenergic neurons are specialized neurons generated from induced pluripotent stem cells (iPSCs) that exhibit the molecular and functional properties of endogenous locus coeruleus noradrenergic neurons. These cells provide a critical in vitro model for studying Parkinson's disease (PD), depression, and norepinephrine-related neurodegeneration["@induced2023"].
<!-- taxonomy-enrichment -->
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000459](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459) | noradrenergic cell |
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000459)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459)
- [OBO Foundry (CL:0000459)](http://purl.obolibrary.org/obo/CL_0000459)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
- [PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | [CL:0000459](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459) | noradrenergic cell | Medium |
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000459)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000459)
- [OBO Foundry (CL:0000459)](http://purl.obolibrary.org/obo/CL_0000459)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [PanglaoDB](https://panglaodb.se/)
Differentiation Protocols
Overview
Differentiation of iPSCs into noradrenergic neurons follows a protocol that recapitulates the development of the locus coeruleus:
Pluripotent Stage (Days 0-7): Maintain iPSCs with BMP4/FGF2
Neural Crest Specification (Days 7-14): Apply WNT and BMP modulators
Noradrenergic Specification (Days 14-28): Use SHH, FGF8, and BMP inhibition
Maturation (Days 28-56): BDNF, GDNF, and cAMP promote terminal differentiation[@directed2022]Key Growth Factors
- FGF8 (Fibroblast Growth Factor 8): Specifies noradrenergic lineage
- SHH (Sonic Hedgehog): Ventral patterning
- BDNF: Survival and maturation
- GDNF: Neuronal maintenance
- db-cAMP: Enhances norepinephrine synthesis
Molecular Characterization
Marker Expression
iPSC-derived noradrenergic neurons express canonical markers:
| Marker | Function | Detection Method |
|--------|----------|------------------|
| TH | Rate-limiting enzyme in catecholamine synthesis | Immunohistochemistry |
| DBH | Dopamine β-hydroxylase | qPCR, Western blot |
| PNMT | Phenylethanolamine N-methyltransferase | Immunohistochemistry |
| PHOX2A/B | Transcription factors | RNA-seq |
| NET (SLC6A2) | Norepinephrine transporter | Functional assay |
Transcriptomic Profile
Single-cell RNA sequencing shows that iPSC-derived noradrenergic neurons cluster with primary locus coeruleus neurons and express characteristic transcription factors including PHOX2A, PHOX2B, and FEV[@singlecell2024].
Electrophysiological Properties
Action Potential Firing
Mature iPSC-derived noradrenergic neurons exhibit:
- Resting Membrane Potential: -50 to -65 mV
- Action Potential Threshold: -35 to -45 mV
- Spike Amplitude: 70-90 mV
- Firing Pattern: Regular spiking with occasional burst firing
- Spontaneous Activity: 1-5 Hz firing rate
Noradrenergic Function
- Norepinephrine Release: Quantifiable via HPLC
- Receptor Expression: α1, α2, β-adrenergic receptors
- Autoreceptor Function: α2-mediated feedback inhibition
Disease Modeling Applications
Parkinson's Disease
iPSC-derived noradrenergic neurons from PD patients show:
- Reduced TH expression: 40-60% decrease[@noradrenergic2023]
- α-Synuclein aggregation: Lewy body-like inclusions
- Mitochondrial dysfunction: Complex I deficits
- Increased oxidative stress: ROS accumulation
Depression
Noradrenergic dysfunction is central to depression pathophysiology:
- NE transporter alterations: Reduced reuptake efficiency
- Receptor dysregulation: α2 autoreceptor hypersensitivity
- Cortical connectivity: Impaired prefrontal cortical modulation
Multiple System Atrophy
These neurons model:
- Autonomic dysfunction: Peripheral noradrenergic deficits
- Neurodegeneration: Progressive locus coeruleus loss
Drug Screening Applications
Therapeutic Targets
SNRIs: Serotonin-norepinephrine reuptake inhibitors
NRIs: Norepinephrine reuptake inhibitors
α2 Antagonists: Noradrenergic enhancers
β-adrenergic modulators: Cognitive enhancement
- Neuronal viability assays
- Norepinephrine release measurements
- cAMP signaling assays
- Calcium imaging for receptor function
Comparison to Locus Coeruleus Neurons
| Property | iPSC-Derived | Primary Human LC |
|----------|--------------|------------------|
| Availability | Unlimited | Very limited |
| Maturation | 6-8 weeks | N/A |
| Purity | 50-70% | Native |
| Functionality | Partial | Full |
Research Applications
In Vitro Disease Modeling
- Genetic risk factor validation
- Environmental toxin screening
- Age-related degeneration studies
Regenerative Medicine
- Cell replacement therapy potential
- Gene therapy vectors
- Bioengineered tissue constructs
Limitations
- Incomplete maturation: May not fully replicate aged neuron physiology
- Variability: Different iPSC lines show variable efficiency
- Species gaps: Human neurons differ from rodent models
See Also
- [Cell Types Index](/cell-types)
- [Technologies Index
- [Diseases Index](/content/diseases)
- [Locus Coeruleus Neurons](/cell-types/technologies-index](/content/technologies)
- [Parkinson's Disease](/diseases/parkinsons-disease)
Pathway Diagram
The following diagram shows the key molecular relationships involving iPSC-Derived Noradrenergic Neurons discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)